IMBECU   20882
INSTITUTO DE MEDICINA Y BIOLOGIA EXPERIMENTAL DE CUYO
Unidad Ejecutora - UE
artículos
Título:
"MODULATION OF THE NORADRENERGIC ACTIVITY INDEX BY NEURAL STIMULUS, AND ITS PARTICIPATION IN OVARIAN ANDROSTENEDIONE RELEASE DURING THE LUTEAL PHASE?.
Autor/es:
BRONZI D; OROZCO AV; DELGADO SM; CASAIS M; RASTRILLA AM; SOSA ZY
Revista:
FERTILITY AND STERILITY
Editorial:
ELSEVIER SCIENCE INC
Referencias:
Lugar: New York; Año: 2011 p. 1211 - 1216
ISSN:
0015-0282
Resumen:
Fertil Steril. 2011 Mar 15;95(4):1211-6. Epub 2010 Dec 3. Modulation of the noradrenergic activity index by neural stimulus, and its participation in ovarian androstenedione release during the luteal phase. Bronzi D, Orozco AV, Delgado SM, Casais M, Rastrilla AM, Sosa ZY. Source Graduate Facultad de Química, Bioquímica y Farmacia, Universidad Nacional de San Luis, and Laboratorio de Biología de la Reproducción, San Luis, Argentina. Abstract OBJECTIVE: To investigate the participation of catecholamines in the association between peripheral innervation and luteal steroidogenesis. DESIGN: Animal study. SETTING: University animal laboratory. ANIMAL(S): Six to eight virgin adult Holtzman-strain female rats in control and experimental groups on diestrus days 1 and 2. INTERVENTION(S): Removal of the coeliac ganglion-superior ovarian nerve-ovary system, with catecholaminergic agonist or antagonist added in the ganglion compartment (experimental group only). The control group received no treatment. MAIN OUTCOME MEASURE(S): Ovarian neurotransmitters and their catabolites measured by reverse-phase high-pressure liquid chromatography, and A(2) measured by radioimmunoassay. RESULT(S): On day 1, dopamine and catabolite increased whereas norepinephrine decreased, and the noradrenergic neuronal activity index was higher. On day 2, dopamine levels decreased, norepinephrine increased, and dopaminergic neuronal activity was higher. The release of A(2) was decreased by addition of norepinephrine to the ganglions on day 1, but was increased by the norepinephrine antagonist on day 2. Hence, norepinephrine increased A(2) release, and propranolol diminished it. CONCLUSION(S): Ganglionic activity is modified by noradrenergic stimulus, leading to different ovarian A(2) release profiles. The peripheral nervous system is a modulator in these homeostatic mechanisms.